| ²é¿´: 914 | »Ø¸´: 7 | ||||
jcgjazzy½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
¡¾ÇóÖú¡¿ÇóÖú2¾äÓ¢ÎÄ·Òë ÒÑÓÐ5È˲ÎÓë
|
|
¿ªÊ¼¿´ÎÄÏ×ÁË£¬ºÃ¶àרҵÊõÓï²»¶®£¬Ï൱µÄÓôÃÆ£¬Çë´ó¼Ò°ïæ·ÒëÏÂÕâÁ½¾ä»°¡£ These compounds were prepared and evaluated for their anti-cancer activity against a panel of 53 human tumour cell lines derived from nine different cancer types. When breast carcinoma cells (MCF-7) were treated with 10 uM concentration of compounds TMAC, CA-4, 6 and 8 cell cycle arrest was observed in G2/M phase. ´ó¼ÒÓкõÄÔÚÏß·ÒëÍøÕ¾Ò²¿ÉÒÔÍÆ¼öÏ£¬ÏÈллÁË£¡ |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸ ½ÄÏ´óѧ 085602 »¯¹¤×¨Ë¶ 338·ÖÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
312Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ²ÄÁϹ¤³Ì£¬³õÊÔ344Çóר˶µ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶322
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
0703»¯Ñ§
ÒѾÓÐ14È˻ظ´
µ÷¼Á Ò»Ö¾Ô¸¼ªÁÖ´óѧ357·Ö
ÒѾÓÐ3È˻ظ´
»¯Ñ§µ÷¼Á
ÒѾÓÐ18È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖú2¾ä»°µÄººÒëÓ¢£¬ÒѸø³ö×Ô¼ºµÄ·Ò룬ҪÇ󵨵À׼ȷµÄ·Òë
ÒѾÓÐ2È˻ظ´
ÇóÓ¢ÎĺÏͬÖÐÒ»¾ä»°µÄ·Ò루ÓÐЧÆÚ½ØÖÁ2ÔÂ8ÈÕ18:00£©
ÒѾÓÐ2È˻ظ´
¼¸¾äÖÐÎÄÒëΪӢÎÄ£¬Çë°ïæУ¶Ôһϣ¬ÇóÖú£¡
ÒѾÓÐ1È˻ظ´
Èý¾äÖÐÎÄ£¬·ÒëΪӢÎÄ£¬ÇóÖú£¡
ÒѾÓÐ2È˻ظ´
ÖÐÎÄ·ÒëΪӢÎÄ£¬Èý¾ä£¬ÇóÖú£¡
ÒѾÓÐ2È˻ظ´
ÇóÖú¼¸¾äÖÐÎÄ·Òë³ÉÓ¢ÎÄ~¼±~
ÒѾÓÐ5È˻ظ´
ÇóÖú2¾äÓ¢ÎÄ·Òë
ÒѾÓÐ4È˻ظ´
ÇóÅ£ÈËÖÐÒëÓ¢·Òë2¾ä»°£¬²»Ê¤¸Ð¼¤
ÒѾÓÐ2È˻ظ´
jiangchunyong
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
-

ר¼Ò¾Ñé: +2 - PhEPI: 2
- Ó¦Öú: 132 (¸ßÖÐÉú)
- ¹ó±ö: 2.626
- ½ð±Ò: 34018.5
- É¢½ð: 183
- ºì»¨: 44
- ɳ·¢: 21
- Ìû×Ó: 14820
- ÔÚÏß: 1602.6Сʱ
- ³æºÅ: 490643
- ×¢²á: 2008-01-03
- רҵ: Ò©Îﻯѧ
- ¹ÜϽ: ҩѧ
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
| ÎÒ¾õµÃÕâ¸öºÜ¼òµ¥°¡ Â¥Ö÷Ó¦¸Ã¶à¿´ÎÄÏ×°¡ |
2Â¥2011-04-06 22:26:17
jiangchunyong
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
-

ר¼Ò¾Ñé: +2 - PhEPI: 2
- Ó¦Öú: 132 (¸ßÖÐÉú)
- ¹ó±ö: 2.626
- ½ð±Ò: 34018.5
- É¢½ð: 183
- ºì»¨: 44
- ɳ·¢: 21
- Ìû×Ó: 14820
- ÔÚÏß: 1602.6Сʱ
- ³æºÅ: 490643
- ×¢²á: 2008-01-03
- רҵ: Ò©Îﻯѧ
- ¹ÜϽ: ҩѧ
¡ï ¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
wtf66(½ð±Ò+1): ¹ÄÀøÏ 2011-04-06 22:38:28
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
wtf66(½ð±Ò+1): ¹ÄÀøÏ 2011-04-06 22:38:28
| ÖÆ±¸ºÍÆÀ¼ÛÕâЩ»¯ºÏÎï¶ÔÓÉ9ÖÖ²»Í¬µÄÖ×Áöϸ°ûÑÜÉú¶øÀ´µÄÒ»×é53ÈËÀàÖ×Áöϸ°ûÖêµÄ¿¹Ö×Áö»îÐÔ¡£µ±ÓÃŨ¶ÈΪ10 uM µÄ»¯ºÏÎïTMAC²âÊÔÈéÏÙ°©(MCF-7)ϸ°ûʱ£¬¿ÉÒԹ۲쵽CA-4, 6 and 8 ϸ°ûÖÜÆÚÍ£ÖÍÔÚG2/MÆÚ£¡´ó¸Å¾ÍÊÇÕâ¸öÒâ˼£¬Äã²Î¿¼Ò»Ï ÎÒûʱ¼ä¸øÄãºÃºÃ·Òë°¡£¡£¡£¡ |
3Â¥2011-04-06 22:35:32
liu-h.q
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 134.7
- É¢½ð: 36
- ºì»¨: 2
- Ìû×Ó: 263
- ÔÚÏß: 127.6Сʱ
- ³æºÅ: 1153198
- ×¢²á: 2010-11-22
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
¡ï ¡ï ¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
jiangchunyong(½ð±Ò+2): лл£¡È·ÊµºÜºÃ£¡ 2011-04-06 22:42:01
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
jiangchunyong(½ð±Ò+2): лл£¡È·ÊµºÜºÃ£¡ 2011-04-06 22:42:01
| ÒÔÒ»×éÀ´×ԾŸö²»Í¬°©Ö¢ÀàÐ͵Ä53ÈËÀàÖ×Áöϸ°ûϵΪ±ê×¼ÕâЩ»ìºÏÎï×¼±¸ÓÃÀ´ÆÀ¹ÀËüÃǵĿ¹°©»îÐÔ¡£µ±ÓÃ10uMŨ¶ÈµÄTMACºÍCA-4»ìºÏÎï´¦ÀíÈéÏÙ°©Ï¸°û(MCF-7)£¬6ÖÁ8ϸ°ûÖÜÆÚ×èÖͿɹ۲쵽G2 / MÆÚ¡£ |
4Â¥2011-04-06 22:40:36
jcgjazzy
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1106.3
- Ìû×Ó: 101
- ÔÚÏß: 53.4Сʱ
- ³æºÅ: 589796
- ×¢²á: 2008-08-30
- ÐÔ±ð: GG
- רҵ: Óлú
5Â¥2011-04-07 00:14:44
jcgjazzy
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1106.3
- Ìû×Ó: 101
- ÔÚÏß: 53.4Сʱ
- ³æºÅ: 589796
- ×¢²á: 2008-08-30
- ÐÔ±ð: GG
- רҵ: Óлú
6Â¥2011-04-07 00:15:09
beniu
½ð³æ (ÕýʽдÊÖ)
- PhEPI: 2
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 0.001
- ½ð±Ò: 12.2
- É¢½ð: 296
- ºì»¨: 20
- Ìû×Ó: 973
- ÔÚÏß: 341.8Сʱ
- ³æºÅ: 840570
- ×¢²á: 2009-09-04
- ÐÔ±ð: GG
- רҵ: ÌìÈ»Óлú»¯Ñ§

7Â¥2011-04-07 07:47:10
caoshiyi2010
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 929.6
- É¢½ð: 25
- ºì»¨: 8
- Ìû×Ó: 186
- ÔÚÏß: 257Сʱ
- ³æºÅ: 1836781
- ×¢²á: 2012-05-27
- ÐÔ±ð: GG
- רҵ: Ì¼ËØ²ÄÁÏÓ볬Ӳ²ÄÁÏ
8Â¥2014-02-24 15:05:14














»Ø¸´´ËÂ¥